CLOV vs LMAT
Clover Health Investments Corp (CLOV) versus LeMaitre Vascular Inc (LMAT) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported LMAT revenue for 2024-12-31 was $219.9M. Net income was $44.0M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
CLOV currently screens at market cap $1.55B. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
Not investment advice. Open the CLOV and LMAT stock pages for the full models.
Not investment advice.